Role of nitric oxide in the promoting effect of HIV type 1 infection and of gp120 envelope glycoprotein on interleukin 4-induced IgE production by normal human mononuclear cells

AIDS Research and Human Retroviruses

Volumn 16, Issue 3, 2000, Pages 251-258

  Dugas, Nathalie ^a   Dereuddre Bosquet, Nathalie ^b   Goujard, Cecile ^c   Dormont, Dominique ^b   Tardieu, Marc ^a   Delfraissy, Jean François ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

^c BICÊTRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 160; GLYCOPROTEIN GP 41; IMMUNOGLOBULIN E; INTERLEUKIN 4; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGLOBULIN PRODUCTION; MONONUCLEAR CELL; PRIORITY JOURNAL;

B-LYMPHOCYTES; CELLS, CULTURED; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP160; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; IMMUNOGLOBULIN E; INTERLEUKIN-4; LEUKOCYTES, MONONUCLEAR; NITRIC OXIDE; RECOMBINANT PROTEINS;

EID: 0034628620     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200309340     Document Type: Article

References (37)

1. 1. Israël-Biet D, Labrousse F, Tourani JM, Sors H, Andrieu JM, and Even PJ: Elevation of IgE in HIV-infected subjects: A marker of poor prognosis. J Allergy Clin Immunol 1992;89:68-75.
2. 2. Wright DN, Nelson RP, Ledford DK, Fernandez-Caldas E, Trudeau WL, and Lockey RF: Serum IgE and human immunodeficiency virus (HIV) infection. J Allergy Clin Immunol 1990;85:445-452.
3. 3. Secord EA, Kleiner, GI, Auci DL, Smith-Norowitz T, Chice S, Finkielstein A, Nowakowski M, Fikrig S, and Durkin HG: IgE against HIV proteins in clinically healthy children with HIV disease. J Allergy Clin Immunol 1996;98:979-984.
4. 4. Koutsonikolis A, Nelson RP, Fernandez-Caldas E, Brigino EN, Seleznick M, Good RA, and Lockey RF: Serum total and specific IgE levels in children infected with human immunodeficiency virus. J Allergy Clin Immunol 1996;97:692-697.
5. 5. Mazza DS, Grieco MH, Reddy MM, and Meriney D: Serum IgE in patients with human immunodeficiency virus infection. Ann Allergy Asthma Immunol 1995;74:411-414.
6. 6. Miguez-Burbano MJ, Shor-Posner G, Fletcher MA, Lu Y, Moreno JN, Carcamo C, Page B, Quesada J, Sauberlich H, and Baum MK: Immunoglobulin E levels in relationship to HIV-1 disease, route of infection, and vitamin E status. Allergy 1995;50:157-161.
7. 7. Shor-Posner G, Miguez-Burbano MJ, Lu Y, Feaster D, Fletcher MA, Sauberlich H, and Baum MK: Elevated IgE level in relationship to nutritional status and immune parameters in early human immunodeficiency. J Allergy Clin Immunol 1994;95:886-892.
8. 8. De Vries JE, Gauchat JF, Aversa GG, Punnonen J, Gascan H, and Yssel H: Regulation of IgE synthesis. Curr Opin Immunol 1991; 3:351-355.
9. 9. Brown MA, Pierce JH, Watson CJ, Falco J, Ihle JN, and Paul WE: B cell stimulatory factor-1/interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 1987;50:908-913.
10. 10. Arock M, Merle-Béral H, Dugas B, Ouazz F, Le Goff L, Vouldoukis I, Mencia-Huerta JM, Schmitt C, Leblond-Missenard V, Debré P, and Mossalayi MD: IL-4 release by human leukemic and activated normal basophils. J Immunol 1993;51:1441-1447.
11. 11. Vercelli D: Regulation of IgE synthesis in humans. J Biol Regul Homeost Agents 1995;9:1-16.
12. 12. Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, and Shearer GM: Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993;91:759-765.
13. 13. Yukawa K, Kikutani H, Owaki K, Yamasaki K, Yokota A, Nakamura H, Barsumina EL, Hardy RR, Suemura M, and Kishimoto T: A B-cell specific differentiation antigen, CD23, is a receptor for IgE (FcεR) on lymphocytes, J Immunol 1987;138:2576-2580.
14. 14. Dugas B, Lagente V, Mencia-Huerta JM, and Braquet P: Pharmacological modulation of the expression of the low affinity IgE receptor. In: Monograph in Allergy (Gordon J, ed.), Vol. 29. Karger Press, Basel, Switzerland, 1990, pp. 76-95.
15. 15. Suemura M and Kishimoto T: IgE class-specific regulatory factor(s) and Fc epsilon receptors on lymphocytes. Int Rev Immunol 1987;2:27-42.
16. 16. Vercelli D, Jabara HH, Lee BW, Woodland N, Geha RS, and Leung DY: Human recombinant interleukin 4 induces FcεR2/CD23 on normal human monocytes. J Exp Med 1988;167:1406-1416.
17. 17. Pène J, Rousset F, Brière F, Chrétien I, Wideman J, Bonnefoy JY, and De Vries JE: Interleukin 5 enhances interleukin 4-induced IgE production by normal human B cells. The role of soluble CD23 antigen. Eur J Immunol 1988;18:929-935.
18. 18. Paul-Eugène N, Pène J, Bousquet J, and Dugas B: Role of cyclic nucleotides and nitric oxide in blood mononuclear cell IgE production stimulated by IL-4. Cytokine 1995;7:61-66.
19. 19. Paul-Eugène N, Kolb JP, Yamaoka K, Damais C, and Dugas B: Regulatory role of nitric oxide in the IL-4-induced IgE production by normal human peripheral blood mononuclear cells. Lymphokine Cytokine Res 1994;13:287-292.
20. 20. Mannick JB, Asano K, Izumi K, Kieff E, and Stamler J: Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 1994;79:1137-1146.
21. 21. Dugas B, Debré P, and Moncada S: Nitric oxide: A vital poison inside the immune and inflammatory network. Res Immunol 1995;146:664-670.
22. 22. Baldeweg T, Sooranna S, Das I, Catalan J, and Cazzard B: Serum nitrite concentration suggests a role for nitric oxide in AIDS. AIDS 1996;10:451-452.
23. 23. Bukrinsky MI, Nottet HSLN, Schmidtmayerova H, Dubrovsky L, Flanagan CR, Mullins ME, Lipton SA, and Gendelman HE: Regulation of nitric oxide synthase activity in human immunodeficiency virus type I (HIV-1)-infected monocytes: Implications for HIV-associated neurological disease. J Exp Med 1995;191:735-745.
24. 24. Pietraforte D, Tritarelli E, Testa U, and Minetti M: gp120 HIV envelope glycoprotein increases the production for nitric oxide in human monocyte-derived macrophages. J Leukocyte Biol 1994;55: 175-182.
25. 25. Kärber G: Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exp Pathol Pharmakol 1931;162:956-959.
26. 26. Pene J, Rousset F, Brière F, Chretien I, Bonnefoy JY, Spits T, Yokota N, Arai K, and Banchereau J: IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha prostaglandin E2. Proc Natl Acad Sci USA 1988;85:6880-6884.
27. 27. Bonnefoy JY, Shields J, and Mermod JJ: Inhibition of human IL-4-induced IgE synthesis by a subset of anti-CD23/FcεRII monoclonal antibodies. Eur J Immunol 1990;20:139-144.
28. 28. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok S, and Tannenbaum SR: Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982;126:131-138.
29. 29. Chirmule N, Kalyanaraman VS, Lederman S, Oyaizu N, Yagura H, Yellin MJ, Chess L, and Pahwa S: HIV-gp160-induced T cell-dependent B cell differentiation. J Immunol 1993;150:2478-2486.
30. 30. Carini C, Margolick J, Yodoi J, and Ishizaka K: Formation of IgE binding factors by lymphocytes of HIV-infected patients. Int Arch Allergy Appl Immunol 1989;88:116-118.
31. H3 gene products: Natural ligands for HIV gp120. Science 1993;261:1588-1591.
32. 32. Yanagihara Y, Basaki Y, Kajiwara K, and Ikizawa K: A thiol antioxidant regulates IgE isotype switching by inhibiting activation of nuclear factor-kappaB. J Allergy Clin Immunol 1997;100:S33-S38.
33. 33. Paganelli R, Scala E, Mezzaroma I, Pinter E, D'Offizi G, Fanales-Belasio E, Rosso RM, Ansotegui IJ, Pandolfi F, and Aiuti F: Immunologic aspects of hyperimmunoglobulinemia E-like syndrome in patients with AIDS. J Allergy Clin Immunol 1995;95:995-1003.
34. 34. Dugas B, Renault JC, Pène J, Bonnefoy JY, Petit-Frère C, Braquet P, Bousquet J, Van Snick J, and Mencia-Huerta JM: Interleukin-9 potentiates the interleukin-4 induced immunoglobulin (IgG, IgM and IgE) production by normal human B lymphocytes. Eur J Immunol 1993;23:1687-1692.
35. 35. Paul-Eugène N, Kolb JP, Calenda A, Gordon J, Kikutani H, Kishimoto T, Mencia-Huerta JM, Braquet P, and Dugas B: Functional interaction between β2-adrenoceptor agonists and interleukin-4 in the regulation of IgE-dependent mechanisms in human. Mol Immunol 1993;30:157-162.
36. 36. Ouaaz F, Ruscetti FW, Dugas B, Mikovitz J, Agut M, Debré P, and Mossalayi MD: Effects of IgE immune complexes on HIV-1 replication and cell death in infected U1 monocytes: Involvement of CD23/FcεRII mediated nitric oxide and cyclic AMP pathway. Mol Med 1996;2:38-49.
37. 37. Fauci AS: Host factors and the pathogenesis of HIV-induced disease. Nature (London) 1996;384:529-534.